| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1045079995 |
| P356 | DOI | 10.1007/S10620-007-9809-1 |
| P698 | PubMed publication ID | 17393310 |
| P50 | author | Ülkü Dağlı | Q61167216 |
| P2093 | author name string | Burhan Sahin | |
| Sedef Kuran | |||
| Nurten Savas | |||
| Esin Ertugrul | |||
| P2860 | cites work | Mortality in systemic sclerosis: an international meta-analysis of individual patient data | Q30980001 |
| Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies | Q33553751 | ||
| Serological markers in progressive systemic sclerosis: clinical correlations | Q33554043 | ||
| Motor disorders of the esophagus | Q34024794 | ||
| Gastrointestinal manifestations of scleroderma | Q34487889 | ||
| Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). | Q34504541 | ||
| Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients | Q34559161 | ||
| Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population | Q35194947 | ||
| Heart involvement and systemic sclerosis. | Q36283456 | ||
| Esophageal disease in scleroderma | Q36610693 | ||
| Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee | Q39513167 | ||
| Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases | Q39912319 | ||
| Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial | Q40700292 | ||
| THE CLINICAL SIGNIFICANCE OF THE ANTICENTROMERE ANTIBODY | Q59032616 | ||
| Esophageal manometry in 95 healthy adult volunteers. Variability of pressures with age and frequency of "abnormal" contractions | Q68987663 | ||
| Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants | Q70240365 | ||
| Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients | Q70740921 | ||
| Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis | Q71002244 | ||
| Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders. A Doppler echocardiographic study of 135 Japanese patients | Q71974999 | ||
| The CREST syndrome: a distinct serologic entity with anticentromere antibodies | Q72080575 | ||
| Severe organ involvement in systemic sclerosis with diffuse scleroderma | Q73202420 | ||
| Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit | Q73313565 | ||
| Autoantibody profile in progressive systemic sclerosis as markers for esophageal involvement | Q73506363 | ||
| Esophageal involvement and pulmonary manifestations in systemic sclerosis | Q74361369 | ||
| Association of esophageal dysfunction and pulmonary function impairment in systemic sclerosis | Q74363603 | ||
| Oesophageal manometry in early and definite systemic sclerosis | Q81128345 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 3081-3086 | |
| P577 | publication date | 2007-03-28 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Autoantibody profile in systemic sclerosis as a marker for esophageal and other organ involvement in Turkish populations | |
| P478 | volume | 52 |
| Q42176643 | Gastrointestinal complications of systemic sclerosis | cites work | P2860 |
Search more.